Trinity Biotech (TRIB) Interest Expenses (2009 - 2024)

Trinity Biotech has disclosed Interest Expenses across 16 years of filings, most recently posting -$3.4 million for Q4 2024.

• Interest Expenses for Q4 2024 came in at -$3.4 million, down 44.67% year-over-year; the trailing twelve-month figure through Dec 2025 was -$6.5 million (up 32.41% YoY), and the FY2025 annual result was $21.4 million, up 123.61% from the prior year.
• Interest Expenses came in at -$3.4 million for Q4 2024 at Trinity Biotech, down from -$3.1 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $8300.0 in Q2 2022 to a low of -$12.2 million in Q1 2022.
• The 5-year median for Interest Expenses is -$2.3 million (2022), against an average of -$2.4 million.
• Across the five-year window, Interest Expenses surged 508.5% in 2022 and sank 46160.24% in 2023, its largest moves.
• Trinity Biotech's Interest Expenses stood at -$1.2 million in 2020, then plunged by 145.18% to -$3.0 million in 2021, then advanced by 20.56% to -$2.4 million in 2022, then rose by 1.97% to -$2.3 million in 2023, then sank by 44.67% to -$3.4 million in 2024.
• The last three Interest Expenses figures came in at -$3.4 million (Q4 2024), -$3.1 million (Q3 2024), and -$2.8 million (Q2 2024), per Business Quant data.